120 related articles for article (PubMed ID: 34913881)
1. Second messengers mediating high-molecular-weight hyaluronan-induced antihyperalgesia in rats with chemotherapy-induced peripheral neuropathy.
Bonet IJM; Staurengo-Ferrari L; Araldi D; Green PG; Levine JD
Pain; 2022 Sep; 163(9):1728-1739. PubMed ID: 34913881
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms Mediating High-Molecular-Weight Hyaluronan-Induced Antihyperalgesia.
Bonet IJM; Araldi D; Khomula EV; Bogen O; Green PG; Levine JD
J Neurosci; 2020 Aug; 40(34):6477-6488. PubMed ID: 32665406
[TBL] [Abstract][Full Text] [Related]
3. CD44 Signaling Mediates High Molecular Weight Hyaluronan-Induced Antihyperalgesia.
Ferrari LF; Khomula EV; Araldi D; Levine JD
J Neurosci; 2018 Jan; 38(2):308-321. PubMed ID: 29175954
[TBL] [Abstract][Full Text] [Related]
4. PI3Kγ/AKT Signaling in High Molecular Weight Hyaluronan (HMWH)-Induced Anti-Hyperalgesia and Reversal of Nociceptor Sensitization.
Bonet IJM; Khomula EV; Araldi D; Green PG; Levine JD
J Neurosci; 2021 Oct; 41(40):8414-8426. PubMed ID: 34417329
[TBL] [Abstract][Full Text] [Related]
5. Topical coapplication of hyaluronan with transdermal drug delivery enhancers attenuates inflammatory and neuropathic pain.
Bonet IJM; Araldi D; Green PG; Levine JD
Pain; 2023 Dec; 164(12):2653-2664. PubMed ID: 37467181
[TBL] [Abstract][Full Text] [Related]
6. Sexual dimorphism in the nociceptive effects of hyaluronan.
Bonet IJM; Green PG; Levine JD
Pain; 2021 Apr; 162(4):1116-1125. PubMed ID: 33065736
[TBL] [Abstract][Full Text] [Related]
7. Sexually Dimorphic Role of Toll-like Receptor 4 (TLR4) in High Molecular Weight Hyaluronan (HMWH)-induced Anti-hyperalgesia.
Bonet IJM; Araldi D; Green PG; Levine JD
J Pain; 2021 Oct; 22(10):1273-1282. PubMed ID: 33892155
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix hyaluronan signals via its CD44 receptor in the increased responsiveness to mechanical stimulation.
Ferrari LF; Araldi D; Bogen O; Levine JD
Neuroscience; 2016 Jun; 324():390-8. PubMed ID: 26996509
[TBL] [Abstract][Full Text] [Related]
9. Involvement of TACAN, a Mechanotransducing Ion Channel, in Inflammatory But Not Neuropathic Hyperalgesia in the Rat.
Bonet IJM; Araldi D; Bogen O; Levine JD
J Pain; 2021 May; 22(5):498-508. PubMed ID: 33232830
[TBL] [Abstract][Full Text] [Related]
10. Macrophage Toll-like Receptor 9 Contributes to Chemotherapy-Induced Neuropathic Pain in Male Mice.
Luo X; Huh Y; Bang S; He Q; Zhang L; Matsuda M; Ji RR
J Neurosci; 2019 Aug; 39(35):6848-6864. PubMed ID: 31270160
[TBL] [Abstract][Full Text] [Related]
11. Role of pattern recognition receptors in chemotherapy-induced neuropathic pain.
Araldi D; Khomula EV; Bonet IJM; Bogen O; Green PG; Levine JD
Brain; 2024 Mar; 147(3):1025-1042. PubMed ID: 37787114
[TBL] [Abstract][Full Text] [Related]
12. Marked sexual dimorphism in neuroendocrine mechanisms for the exacerbation of paclitaxel-induced painful peripheral neuropathy by stress.
Ferrari LF; Araldi D; Green PG; Levine JD
Pain; 2020 Apr; 161(4):865-874. PubMed ID: 31917777
[TBL] [Abstract][Full Text] [Related]
13. Sexual dimorphism in the contribution of neuroendocrine stress axes to oxaliplatin-induced painful peripheral neuropathy.
Staurengo-Ferrari L; Green PG; Araldi D; Ferrari LF; Miaskowski C; Levine JD
Pain; 2021 Mar; 162(3):907-918. PubMed ID: 32947545
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine mechanisms in oxaliplatin-induced hyperalgesic priming.
Staurengo-Ferrari L; Araldi D; Green PG; Levine JD
Pain; 2023 Jun; 164(6):1375-1387. PubMed ID: 36729863
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.
Joseph EK; Chen X; Bogen O; Levine JD
J Pain; 2008 May; 9(5):463-72. PubMed ID: 18359667
[TBL] [Abstract][Full Text] [Related]
17. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain.
Li Y; North RY; Rhines LD; Tatsui CE; Rao G; Edwards DD; Cassidy RM; Harrison DS; Johansson CA; Zhang H; Dougherty PM
J Neurosci; 2018 Jan; 38(5):1124-1136. PubMed ID: 29255002
[TBL] [Abstract][Full Text] [Related]
18. Bioenergetic deficits in peripheral nerve sensory axons during chemotherapy-induced neuropathic pain resulting from peroxynitrite-mediated post-translational nitration of mitochondrial superoxide dismutase.
Janes K; Doyle T; Bryant L; Esposito E; Cuzzocrea S; Ryerse J; Bennett GJ; Salvemini D
Pain; 2013 Nov; 154(11):2432-2440. PubMed ID: 23891899
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity.
Micheli L; Di Cesare Mannelli L; Rizzi A; Guerrini R; Trapella C; Calò G; Ghelardini C
Eur J Pharmacol; 2015 Nov; 766():155-62. PubMed ID: 26450087
[TBL] [Abstract][Full Text] [Related]
20. Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity.
Minami T; Takeda M; Sata M; Kato H; Yano K; Sakai T; Tsujita R; Kawasaki K; Ito A
Eur J Pharmacol; 2020 Aug; 880():173196. PubMed ID: 32416186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
